Journal of Antimicrobial Chemotherapy (2001) 48, 219-223
© 2001 The British Society for Antimicrobial Chemotherapy
The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates
Department of Infection, KCL, St Thomas' Hospital Campus, London SE1 7EH, UK
The in vitro activity of daptomycin was assessed in comparison with that of vancomycin and penicillin against a wide range of Gram-positive aerobic clinical isolates. MICs were determined by an agar dilution method on MuellerHinton agar (NCCLS/EUCAST) and on Isotonic agar adjusted to contain 50 mg/L free calcium (BSAC). Both media were enriched with 5% horse blood for fastidious organisms. Daptomycin MICs for all 172 staphylococci, including methicillin-susceptible and methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis and Staphylococcus haemolyticus, were 0.030.5 mg/L. For 99 of the 100 enterococci (Enterococcus faecalis, n = 50; Enterococcus faecium, n = 50), including 37 vancomycin-resistant isolates, they were 0.252 mg/L. For all 108 ß-haemolytic streptococci, including Streptococcus pyogenes and Streptococcus agalactiae, daptomycin MICs were 0.016 0.25 mg/L; for 101
-haemolytic streptococci, including Streptococcus pneumoniae and viridans streptococci, they were 0.0162 mg/L. For miscellaneous vancomycin-resistant isolates including Lactobacillus spp., Lactococcus spp., Leuconostoc spp., Pediococcus spp. and isolates of Enterococcus casseliflavus and Enterococcus gallinarum, daptomycin MICs were 0.032 mg/L; MICs for the seven isolates of Listeria monocytogenes were 0.254 mg/L. There was little difference between the results on MuellerHinton agar and on supplemented Isotonic agar The discrepant results occasionally obtained tended to be one dilution higher on supplemented Isotonic agar. Daptomycin was active (MICs
2 mg/L) against all the isolates tested with the exception of one isolate each of E. faecium and L. monocytogenes (MICs = 4 mg/L). Our results indicate that daptomycin MICs are independent of methicillin and vancomycin MICs.
* Corresponding author. Tel: +44-20-7928-9292 ext. 2456; Fax: +44-20-7928-0730; E-mail: anna.king{at}kcl.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Cotroneo, R. Harris, N. Perlmutter, T. Beveridge, and J. A. Silverman Daptomycin Exerts Bactericidal Activity without Lysis of Staphylococcus aureus Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2223 - 2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Spanjaard and C. M. J. E. Vandenbroucke-Grauls Activity of Daptomycin against Listeria monocytogenes Isolates from Cerebrospinal Fluid Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1850 - 1851. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Attwood and K. L. LaPlante Telavancin: A novel lipoglycopeptide antimicrobial agent Am. J. Health Syst. Pharm., November 15, 2007; 64(22): 2335 - 2348. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Klare, C. Konstabel, S. Muller-Bertling, R. Reissbrodt, G. Huys, M. Vancanneyt, J. Swings, H. Goossens, and W. Witte Evaluation of New Broth Media for Microdilution Antibiotic Susceptibility Testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria Appl. Envir. Microbiol., December 1, 2005; 71(12): 8982 - 8986. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Miao, M.-F. Coeffet-LeGal, P. Brian, R. Brost, J. Penn, A. Whiting, S. Martin, R. Ford, I. Parr, M. Bouchard, et al. Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry Microbiology, May 1, 2005; 151(5): 1507 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Streit, J. N. Steenbergen, G. M. Thorne, J. Alder, and R. N. Jones Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis J. Antimicrob. Chemother., April 1, 2005; 55(4): 574 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cottagnoud, M. Pfister, F. Acosta, M. Cottagnoud, L. Flatz, F. Kuhn, H.-P. Muller, and A. Stucki Daptomycin Is Highly Efficacious against Penicillin-Resistant and Penicillin- and Quinolone-Resistant Pneumococci in Experimental Meningitis Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3928 - 3933. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Lai and S. K Brodeur Physical and Chemical Compatibility of Daptomycin with Nine Medications Ann. Pharmacother., October 1, 2004; 38(10): 1612 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Johnson, S. Mushtaq, M. Warner, and D. M. Livermore Calcium-supplemented daptomycin Etest strips for susceptibility testing on Iso-Sensitest agar J. Antimicrob. Chemother., May 1, 2004; 53(5): 860 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Fluit, F.-J. Schmitz, J. Verhoef, and D. Milatovic In Vitro Activity of Daptomycin against Gram-Positive European Clinical Isolates with Defined Resistance Determinants Antimicrob. Agents Chemother., March 1, 2004; 48(3): 1007 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Phillips, M. Casewell, T. Cox, B. De Groot, C. Friis, R. Jones, C. Nightingale, R. Preston, and J. Waddell Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data J. Antimicrob. Chemother., January 1, 2004; 53(1): 28 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alder, T. Li, D. Yu, L. Morton, J. Silverman, X.-X. Zhang, I. Critchley, and G. Thorne Analysis of Daptomycin Efficacy and Breakpoint Standards in a Murine Model of Enterococcus faecalis and Enterococcus faecium Renal Infection Antimicrob. Agents Chemother., November 1, 2003; 47(11): 3561 - 3566. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. K. Dandekar, P. R. Tessier, P. Williams, C. H. Nightingale, and D. P. Nicolau Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model J. Antimicrob. Chemother., September 1, 2003; 52(3): 405 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Silverman, N. G. Perlmutter, and H. M. Shapiro Correlation of Daptomycin Bactericidal Activity and Membrane Depolarization in Staphylococcus aureus Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2538 - 2544. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Laganas, J. Alder, and J. A. Silverman In Vitro Bactericidal Activities of Daptomycin against Staphylococcus aureus and Enterococcus faecalis Are Not Mediated by Inhibition of Lipoteichoic Acid Biosynthesis Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2682 - 2684. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vaudaux, P. Francois, C. Bisognano, D. Li, D. P. Lew, and J. Schrenzel Comparative efficacy of daptomycin and vancomycin in the therapy of experimental foreign body infection due to Staphylococcus aureus J. Antimicrob. Chemother., July 1, 2003; 52(1): 89 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Richter, D. E. Kealey, C. T. Murray, K. P. Heilmann, S. L. Coffman, and G. V. Doern The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species J. Antimicrob. Chemother., July 1, 2003; 52(1): 123 - 127. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Critchley, R. S. Blosser-Middleton, M. E. Jones, C. Thornsberry, D. F. Sahm, and J. A. Karlowsky Baseline Study To Determine In Vitro Activities of Daptomycin against Gram-Positive Pathogens Isolated in the United States in 2000-2001 Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1689 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Critchley, D. C. Draghi, D. F. Sahm, C. Thornsberry, M. E. Jones, and J. A. Karlowsky Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001 J. Antimicrob. Chemother., March 1, 2003; 51(3): 639 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Pankuch, M. R. Jacobs, and P. C. Appelbaum Bactericidal activity of daptomycin against Streptococcus pneumoniae compared with eight other antimicrobials J. Antimicrob. Chemother., February 1, 2003; 51(2): 443 - 446. [Abstract] [Full Text] [PDF] |
||||





